FC
AZN icon

Farringdon Capital’s AstraZeneca AZN Stock Holding History

Farringdon Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$852K Buy
4,495
+411
+10% +$77.3K 0.42% 42
2026
Q1 		$805K Sell
4,084
-5,673
-58% -$1.09M 0.18% 161
2025
Q4 		$1.79M Sell
9,757
-1,593
-14% -$279K 0.44% 61
2025
Q3 		$1.74M Buy
+11,350
New +$1.72M 0.44% 52

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Farringdon Capital's AZN Position: Q2 2026 in Review

Farringdon Capital increased its AstraZeneca (AZN) stake by 10% in Q2 2026, buying an estimated $77.3K and bringing the position to 4,495 shares worth $852K. The position accounts for 0.42% of the portfolio, ranked #42.

Farringdon Capital first reported a position in AZN in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.79M in Q4 2025. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Farringdon Capital held 4,495 shares of AstraZeneca worth $852K as of Q2 2026.
  • Farringdon Capital bought 411 AstraZeneca shares in Q2 2026, an estimated $77.3K.
  • AstraZeneca made up 0.42% of Farringdon Capital's portfolio in Q2 2026, its #42 holding.
  • Farringdon Capital first reported a position in AstraZeneca in Q3 2025 and has held it in 4 quarters since.
  • Farringdon Capital's AstraZeneca position peaked at $1.79M in Q4 2025.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Farringdon Capital's 13F filing for Q2 2026, filed 12 Aug 2026.